SYNH - INCリサ―チ・ホ―ルディングス (Syneos Health Inc.)


   Syneos Health Q3 2021 Earnings Preview  2021/11/02 17:36:35 Seeking Alpha
   Syneos Health, Inc. (NASDAQ:SYNH) Shares Purchased by Squarepoint Ops LLC  2021/10/31 15:22:43 Dakota Financial News
Squarepoint Ops LLC increased its holdings in shares of Syneos Health, Inc. (NASDAQ:SYNH) by 46.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 120,468 shares of the companys stock after purchasing an additional 37,990 shares during the quarter. Squarepoint Ops LLC owned 0.12% []
   Virginia Retirement Systems ET AL Buys New Shares in Syneos Health, Inc. (NASDAQ:SYNH)  2021/10/24 10:26:46 Transcript Daily
Virginia Retirement Systems ET AL bought a new position in Syneos Health, Inc. (NASDAQ:SYNH) in the 2nd quarter, according to its most recent disclosure with the SEC. The firm bought 2,400 shares of the companys stock, valued at approximately $215,000. Other large investors also recently bought and sold shares of the company. FMR LLC lifted []
   Healthcare Staffing Market to See Huge Growth by 2026 | Syneos Health, TeamHealth, Jackson Healthcare  2021/10/22 19:42:00 iCrowdNewswire
A Latest intelligence report published by AMA Research with title Healthcare Staffing Market Outlook to 2026. A detailed study accumulated to offer Latest insights about acute features of the Global Healthcare Staffing Market. This report provides a detailed overview of []
   Silvercrest Asset Management Group LLC Has $22.75 Million Stock Holdings in Syneos Health, Inc. (NASDAQ:SYNH)  2021/10/22 16:20:42 Dakota Financial News
Silvercrest Asset Management Group LLC reduced its position in shares of Syneos Health, Inc. (NASDAQ:SYNH) by 1.5% during the second quarter, Holdings Channel reports. The institutional investor owned 254,185 shares of the companys stock after selling 3,763 shares during the period. Silvercrest Asset Management Group LLCs holdings in Syneos Health were worth $22,747,000 as of []
   Syneos Health partners with Ride Health to improve clinical trial recruitment  2021/09/09 13:31:01 Seeking Alpha
   Novan Engages Syneos Health as Commercial Solutions Provider for SB206  2021/09/08 13:00:00 Intrado Digital Media
Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in patients with molluscum contagiosum
   The Daily Biotech Pulse: MacroGenics'' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA''s FDA Nod  2021/09/08 11:32:07 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Candel Therapeutics, Inc. (NASDAQ: CADL ) (announced completion of patient enrollment in the pivotal phase 3 study of CAN-2409 in prostate cancer) Cardiol Therapeutics Inc. (NASDAQ: CRDL ) (announced addition to its board) Caribou Biosciences, Inc. (NASDAQ: CRBU ) Catalent, Inc. (NASDAQ: CTLT ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN ) Edwards Lifesciences Corporation (NYSE: EW ) Erasca, Inc. (NASDAQ: ERAS ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Imago BioSciences, Inc. (NASDAQ: IMGO ) INmune Bio, Inc. (NASDAQ: INMB ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Lyell Immunopharma, Inc. (NASDAQ: LYEL ) Medpace Holdings, Inc. (NASDAQ: MEDP ) MiMedx Group, Inc. (NASDAQ: MDXG ) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) Nuvalent, Inc. (NASDAQ: NUVL ) PAVmed Inc. (NASDAQ: PAVM ) Protagonist Therapeutics, Inc. (NASDAQ: PTGX ) (reacted to an executive appointment) Psychemedics Corporation (NASDAQ: PMD ) Quest Diagnostics Incorporated (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) Repligen Corporation (NASDAQ: RGEN ) ShockWave Medical, Inc. (NASDAQ: SWAV ) Surrozen, Inc. (NASDAQ: SRZN ) ( reacted to positive analyst action) Syneos Health, Inc. (NASDAQ: SYNH ) Tandem Diabetes Care, Inc. (NASDAQ: TNDM ) (reacted to the news of inclusion of the stock to the S&P MidCap 400 Index) Tango Therapeutics, Inc. (NASDAQ: TNGX ) Verve Therapeutics, Inc. (NASDAQ: VERV ) Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL ) Down In The Dumps No NYSE- or Nasdaq-listed stock hit 52-week lows Tuesday.
   Syneos Health Inc (SYNH) CFO Jason M. Meggs Sold $876,185 of Shares  2021/09/04 00:15:01 GuruFocus
Related Stocks: SYNH ,
   Syneos Health Inc (SYNH): Price Now Near $94.48; Daily Chart Shows An Uptrend on 20 Day Basis  2021/09/03 15:18:24 ETF Daily News
Regarding the trend, note that the strongest trend exists on the 100 day timeframe. The post Syneos Health Inc (SYNH): Price Now Near $94.48; Daily Chart Shows An Uptrend on 20 Day Basis appeared first on ETF Daily News .
   Healthcare Staffing Market: Approach to Gain Momentum by Players - Cross Country Healthcare, Inc., AMN Healthcare, Syneos Health, Inc., CHG Management, Inc., Maxim Healthcare Services, Inc.  2021/08/31 13:29:56 OpenPR
According to Decisive Markets Insights'' New Report "Healthcare Staffing Market ", it analyses the competitive landscape and its future growth prospects. For the analysis period of 2020 - 2027, the report of the Market includes a detailed study of some
   The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical  2021/08/31 12:05:06 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN ) Alkermes plc (NASDAQ: ALKS ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Techne Corporation (NASDAQ: TECH ) BioLife Solutions, Inc. (NASDAQ: BLFS ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Clearside Biomedical, Inc. (NASDAQ: CLSD ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Cytokinetics, Incorporated (NASDAQ: CYTK ) Dermata Therapeutics, Inc. (NASDAQ: DRMA ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eliem Therapeutics, Inc. (NASDAQ: ELYM ) (IPOed Aug. 10) Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA ) IVERIC bio, Inc. (NASDAQ: ISEE ) Kezar Life Sciences, Inc. (NASDAQ: KZR ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) MiMedx Group, Inc. (NASDAQ: MDXG ) PDS Biotechnology Corporation (NASDAQ: PDSB ) Pieris Pharmaceuticals, Inc.
   Syneos Health to Present at the 2021 Baird Global Healthcare Conference  2021/08/30 13:00:00 Intrado Digital Media
MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the 2021 Baird Global Healthcare Conference on September 15, 2021, at 1:25 p.m. ET.
   Clinical Trial Services Market Significantly Stepping towards the Success Till 2027| Labcorp, IQVIA, Syneos Health, Parexel  2021/08/16 13:47:39 OpenPR
Support for Clinical Trials Over the previous few years, the market has grown at a faster rate, with significant growth rates. The increasing interest of pharmaceutical corporations in producing and sponsoring clinical trials and drug development is a major driver
   Earnings: Bandwidth, Syneos Health beat Street; Asensus Surgical reports loss | WRAL TechWire  2021/08/09 17:55:08 WRAL TechWire
Earnings season continues with Triangle area firms reporting more financial updates, including Bandwidth, Syneos Health and Asensus Surgical (formerly known as